Literature DB >> 10750037

Expression of ErbB receptors during pancreatic islet development and regrowth.

M R Kritzik1, T Krahl, A Good, D Gu, C Lai, H Fox, N Sarvetnick.   

Abstract

We have characterized expression of the ErbB receptor family and one of its ligands, heregulin, in an effort to identify molecules associated with pancreatic development and regeneration. In addition to studying expression during fetal pancreatic development, we have also studied expression during pancreatic regeneration in the interferon-gamma (IFNgamma)-transgenic mouse, which exhibits significant duct cell proliferation and new islet formation. These studies demonstrate significant expression of the ErbB2, ErbB3, and ErbB4 receptors, in addition to heregulin isoforms, in the developing murine fetal pancreas. We also report significant ductal expression of these proteins during IFNgamma-mediated pancreatic regeneration. This striking expression was absent in 1-week-old neonates, but was clearly visible in pups by 5 weeks of age. These data therefore indicate that ErbB receptor and ligand expression decline by birth in both the IFNbeta-transgenic and non-transgenic mice, and that expression resumes early in postnatal life in the IFNbeta-transgenic mice. The expression of ErbB receptor family members at sites of islet development and regrowth suggests that these molecules might be relevant to these processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750037     DOI: 10.1677/joe.0.1650067

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  17 in total

1.  ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Authors:  J Spencer Liles; Juan Pablo Arnoletti; Ching-Wei D Tzeng; J Harrison Howard; Andrew V Kossenkov; Peter Kulesza; Martin J Heslin; Andrey Frolov
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

Review 2.  β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor.

Authors:  Amanda Oakie; Rennian Wang
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

3.  Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.

Authors:  Christopher P Mill; Kathleen L Gettinger; David J Riese
Journal:  Exp Cell Res       Date:  2010-11-24       Impact factor: 3.905

4.  Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation.

Authors:  E Hakonen; J Ustinov; I Mathijs; J Palgi; L Bouwens; P J Miettinen; T Otonkoski
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

5.  Induction of mouse pancreatic ductal differentiation, an in vitro assay.

Authors:  Julie A Rhodes; Angela Criscimanna; Farzad Esni
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-10-24       Impact factor: 2.416

6.  In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes.

Authors:  Elina Hakonen; Jarkko Ustinov; Décio L Eizirik; Hannu Sariola; Päivi J Miettinen; Timo Otonkoski
Journal:  Diabetologia       Date:  2014-02-04       Impact factor: 10.122

7.  Simultaneous profiling of 194 distinct receptor transcripts in human cells.

Authors:  Byong H Kang; Karin J Jensen; Jaime A Hatch; Kevin A Janes
Journal:  Sci Signal       Date:  2013-08-06       Impact factor: 8.192

8.  The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?

Authors:  Scott A Soleimanpour; Doris A Stoffers
Journal:  Trends Endocrinol Metab       Date:  2013-05-03       Impact factor: 12.015

9.  Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha.

Authors:  Mylène Heinis; Marie-Thérèse Simon; Karine Ilc; Nathalie M Mazure; Jacques Pouysségur; Raphael Scharfmann; Bertrand Duvillié
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

10.  Statistical methods for gene set co-expression analysis.

Authors:  YounJeong Choi; Christina Kendziorski
Journal:  Bioinformatics       Date:  2009-08-18       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.